SPARC protein expression was significantly associated with interstitial remodeling, the loss of CD34, and α-SMA expression in invasive ductal carcinoma and interfered with TGF-β1 signaling, which allowed it to play a role in tumor progression [38]. This evidence concerns the gene TGFB1 and invasive ductal breast carcinoma.